Search Within

Biostatistics Service

Formats
  1. Journal Article (4057)
  2. Meeting Abstract (2453)
  3. Research Letter (55)
  4. Conference Paper (37)
  5. Correspondence (28)
  6. Editorial (26)
  7. Review (23)
  8. Miscellaneous (16)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Epidemiology and Biostatistics (6713)
  2. Department of Medicine (3955)
  3. Solid Tumor Oncology Division (2629)
  4. Survivorship Research (2555)
  5. Surgery (2427)
  6. Population Sciences Research Program (2413)

More Groups

People
  1. Mithat Gonen (1041)
  2. Sean Devlin (618)
  3. Katherine Panageas (525)
  4. Sujata Patil (511)
  5. Sergio Giralt (480)
  6. Zhigang Zhang (434)

More People

Years
  1. 2025 (227)
  2. 2024 (402)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1078)
  2. Blood (468)
  3. Annals of Surgical Oncology (312)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (198)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1148)
  2. Elsevier Inc. (780)
  3. Springer (635)
  4. American Society of Hematology (527)
  5. American Association for Cancer Research (434)
  6. Nature Publishing Group (317)

More Publishers

Results (6713)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The prospective impact of radical cystectomy and urinary diversions on the health-related quality of life of bladder cancer patients
    Meeting Abstract

    Atkinson, T.; Bochner, B.; Kim, S. Y.; Rapkin, B.; Li, Y.
    Quality of Life Research (2019)

    Fulltext@MSK | Save
  • Discovering patient clusters and their unique quality of life profiles with the Infinite Relational Model
    Meeting Abstract

    Li, Y.; Kim, S. Y.; Atkinson, T.; Bochner, B.
    Quality of Life Research (2019)

    Fulltext@MSK | Save
  • Pneumatosis intestinalis in the pediatric oncology population: An eleven year retrospective review at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Bailey, K.; Kodikara, H.; Price, A.; Mauguen, A.; LaQuaglia, M.; Boulad, F.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save